Latest filing published 23 Aug 2024 for Immunovant, Inc., €83k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Julia G. Butchko: trading record in brief
Julia G. Butchko is a declared insider of Immunovant, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 11 September 2020 and 21 August 2024, the trades on record add up to 36 filings.
The open-market side counts 1 purchase for €161k alongside 30 sales for €2.5M. Taken together, the sales exceed the purchases by €2.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 5 share grants. So far in 2024, the count stands at no purchases and 11 sales.
The record was last updated on 23 August 2024 with an open-market sale (€3,477) in Immunovant, Inc. The clock since the last published purchase (15 September 2020) now reads 2,246 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Julia G. Butchko
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,907 shares@ US$31.844.6% of flowCommon StockSEC:0001764013-24-000157:0
- 2,698 shares@ US$29.644.1% of flowCommon StockSEC:0001764013-24-000134:0
- 1,527 shares@ US$28.062.2% of flowCommon StockSEC:0001764013-24-000126:0
- 3,247 shares@ US$29.655.0% of flowCommon StockSEC:0001764013-24-000097:0
- 7,825 shares@ US$28.8011.8% of flowCommon StockSEC:0001764013-24-000077:0
- 1,053 shares@ US$31.181.7% of flowCommon StockSEC:0001764013-24-000071:0
- 54,978 shares0Common StockSEC:0001764013-24-000048:0
- 2,146 shares@ US$36.154.0% of flowCommon StockSEC:0001764013-24-000038:0
- 1,297 shares@ US$38.592.5% of flowCommon StockSEC:0001764013-24-000007:0
- 3,141 shares@ US$32.755.3% of flowCommon StockSEC:0001764013-23-000141:0
- 296 shares@ US$35.540.6% of flowCommon StockSEC:0001764013-23-000118:0
- 12,332 shares@ US$20.3012.9% of flowCommon StockSEC:0001764013-23-000101:0
- 1,470 shares@ US$19.731.5% of flowCommon StockSEC:0001764013-23-000077:0
- 1,544 shares@ US$15.271.2% of flowCommon StockSEC:0001764013-23-000051:0
- 100,188 shares0Common StockSEC:0001764013-23-000042:0
- 19 shares@ US$15.160.0% of flowCommon StockSEC:0001764013-23-000010:0
- 928 shares@ US$9.180.5% of flowCommon StockSEC:0001764013-22-000132:0
- 535 shares@ US$4.670.1% of flowCommon StockSEC:0001764013-22-000124:0
- 548 shares@ US$5.830.2% of flowCommon StockSEC:0001764013-22-000111:0
- 112,816 shares0Common StockSEC:0001764013-22-000103:0
- 510 shares@ US$4.270.1% of flowCommon StockSEC:0001764013-22-000078:0
- 460 shares@ US$4.020.0000% mcap0.2% of flowCommon StockSEC:0001764013-22-000071:0
- 492 shares@ US$3.790.1% of flowCommon StockSEC:0001764013-22-000047:0
- 541 shares@ US$4.720.2% of flowCommon StockSEC:0001764013-22-000043:0
- 6,381 shares@ US$5.902.4% of flowCommon StockSEC:0001764013-22-000037:0
25 of 27 declarations
